Biomarin Pharmaceutical Inc (BMRN)
71.48
-0.05
(-0.07%)
USD |
NASDAQ |
Mar 26, 16:00
71.21
-0.27
(-0.38%)
Pre-Market: 08:09
Biomarin Pharmaceutical Price to Book Value: 2.410 for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc | 1.620 |
| Moderna Inc | 1.116 |
| Alnylam Pharmaceuticals Inc | 519.48 |
| Gilead Sciences Inc | 7.040 |
| Sarepta Therapeutics Inc | 4.629 |
Price to Book Value Related Metrics
| PE Ratio | 32.49 |
| PS Ratio | 4.970 |
| PEG Ratio | 0.2166 |
| Price to Free Cash Flow | 29.83 |
| Price | 71.48 |
| Earnings Yield | 3.08% |
| Market Cap | 13.64B |
| PEGY Ratio | 0.2166 |
| Operating PE Ratio | 29.91 |
| Normalized PE Ratio | 33.13 |